Luciano Zardi

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Philogen S.p.a., Bayer Schering Pharma Ag. Active years: 2006-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luciano Zardi. Retrieved from https://idiyas.com/inventor/luciano-zardi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 2)

% Patents Active = 42.9

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 30(Granted Patents)

Location History:

Recco, IT (2006)
Genoa, IT (2007 - 2015)

Company Filing History:

Bayer Schering Pharma Ag

patents

where one patent can have more than one assignee

Years Active: 2006-2015

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9096670 - Antibodies of the ED-B domain of fibronectin, their construction and uses (2015-08-04),

2. 8784824 - Compositions and methods for treatment of angiogenesis in pathological lesions (2014-07-22),

3. 8703143 - Antibodies of the ED-B domain of fibronectin, their construction and uses (2014-04-22),

4. 8623373 - Compositions and methods for treatment of angiogenesis in pathological lesions (2014-01-07),

5. 8491906 - Selective targeting of tumor vasculature using antibody molecules (2013-07-23),

6. 7273924 - Antibodies to the ED-B domain of fibronectin, their construction and uses (2007-09-25),

7. 7109301 - Tenascin-C isoform as marker for neoplasias (2006-09-19),

Title: Innovations and Contributions of Luciano Zardi

Introduction

Luciano Zardi is a prominent inventor based in Genoa, Italy, known for his significant contributions to the field of biotechnology. With a total of seven patents to his name, Zardi has made remarkable advancements in the understanding and treatment of various medical conditions.

Latest Patents

Among his latest patents is the invention of antibodies targeting the ED-B domain of fibronectin. This invention provides a specific binding member that directly interacts with the ED-B oncofoetal domain of fibronectin. Additionally, Zardi has developed compositions and methods for treating angiogenesis in pathological lesions. This includes treatments for conditions such as tumors, rheumatoid arthritis, diabetic retinopathy, age-related muscular degeneration, and angiomas. His innovative approach utilizes a conjugate that combines a biocidal or cytotoxic molecule with an antibody directed against extracellular matrix components present in these lesions.

Career Highlights

Throughout his career, Zardi has worked with notable companies such as Philogen S.p.a. and Bayer Schering Pharma AG. His work in these organizations has allowed him to further his research and development in the field of biotechnology.

Collaborations

Zardi has collaborated with esteemed colleagues, including Barbara Carnemolla and Dario Neri, contributing to the advancement of innovative solutions in medical science.

Conclusion

Luciano Zardi's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.